Daniel808
SENIOR MEMBER
- Joined
- Nov 24, 2013
- Messages
- 4,960
- Reaction score
- -8
- Country
- Location
ORIGINAL NEWS IN BAHASA
English Translation from Original News
So Indonesian Health Ministry prefer Chinese Vaccine from (Sinovac and Sinopharm) because they don't need Huge Massive Investment to provide Cooling system for such Extreme Cold Temperature ( - 70 degree celcius) for US Vaccine to distribute it across the islands.
Meanwhile Chinese Vaccine from Sinovac & Sinopharm only need 2 to 8 degree celcius for storing and distribution across the islands. It much easier and can use normal refrigerator for distribution.
Anyway Indonesian KALBE FARMA already have a Cooperation Project with SINOVAC and SINOPHARM for National Vaccination Program. Good luck for cooperation of both countries
Advantages of Chinese Covid-19 Vaccines compared to other countries vaccine
Chinese people is famous to make an Efficient but also effective products.
Part of the practicality of Chinese culture
https://finance.detik.com/industri/...-kepincut-dengan-vaksin-pfizer-ini-jawabannyaRI Kok Nggak Kepincut dengan Vaksin Pfizer? Ini Jawabannya
Trio Hamdani - detikFinance
Jumat, 20 Nov 2020 23:27 WIB
16 komentar
Ilustrasi/Foto: DW (News)
Jakarta-
Perusahaan farmasi asal Amerika Serikat (AS), Pfizer, yang bekerja sama dengan BioNTech mengklaim vaksin mereka sudah efektif 95% untuk mencegah virus Corona (COVID-19). Kenapa Indonesia tak memilih vaksin tersebut?
Direktur Utama Bio Farma Honesti Basyir menerangkan vaksin ini erat kaitannya dengan masalah distribusi. Indonesia tidak mau vaksin yang pada uji klinis bagus, tapi karena proses distribusinya tidak bagus mengakibatkan kerusakan.
Untuk itu, Indonesia turut mempertimbangkan kemampuan untuk distribusi setiap kandidat vaksin yang dipilih.
"Sebagai contoh yang Pfizer itu memang dia baru rilis ya hasil uji klinis dia, mengatakan efektivitasnya di atas 96%, tapi kondisi storage-nya itu minus 70 derajat Celcius. Itu Indonesia belum memiliki kemampuan seperti itu, dan bahaya sekali kalau vaksin ini tidak disimpan di suhu yang sebenarnya, dia akan rusak sehingga nantinya pada saat diberikan kepada masyarakat ini akan berbahaya," katanya dalam acara bertajuk Indonesia Townhall di salah satu stasiun televisi nasional, Jumat (20/11/2020).
"Kalau kita harus menggunakan Pfizer sebagai contoh ataupun Moderna, kita harus membikin serangkaian pengadaan lagi untuk storage-storage yang kemampuannya ekstrem, minus 70 atau minus 20 (derajat Celcius)," jelas Honesti.
Sejauh ini, kandidat vaksin yang dipilih Indonesia dapat disimpan pada temperatur antara 2 sampai 8 derajat Celcius. Secara kemampuan, Indonesia sanggup menanganinya.
"Kita dalam hal ini dengan pemerintah juga makanya ditetapkan oleh Perpres bahwa untuk jenis (vaksin) itu ditetapkan oleh Kementerian Kesehatan. Tentunya sudah ada kriteria tertentu yang membuat nanti Indonesia bisa deliver vaksin itu lebih cepat, mulai dari pengembangannya ataupun pengadaannya, sampai nanti distribusi dan program vaksinasinya ke masyarakat," tambahnya.
English Translation from Original News
https://finance.detik.com/industri/...-kepincut-dengan-vaksin-pfizer-ini-jawabannyaWhy INDONESIA isn't Prefer Pfizer Vaccine? This is the answer
Trio Hamdani - detikFinance
Friday, 20 Nov 2020 23:27 WIB
16 comments
Ilustrasi/Foto: DW (News)
Jakarta-The pharmaceutical company from the United States (US), Pfizer, in collaboration with BioNTech, claims their vaccine is 95% effective in preventing the Corona virus (COVID-19). Why didn't Indonesia choose the vaccine?
Director of Bio Farma Honesti Basyir explained that this vaccine is closely related to distribution problems. Indonesia does not want a vaccine that is in good clinical trials, but because the distribution process is not good it causes damage.
For this reason, Indonesia also considers the ability to distribute each selected vaccine candidate.
"For example, Pfizer has just released the results of his clinical trial, saying that the effectiveness is above 96%, but the storage conditions are minus 70 degrees Celsius. That is Indonesia does not have such capabilities, and it is very dangerous if this vaccine is not stored at the actual temperature, it will be damaged so that later when it is given to the public it will be dangerous, "he said in an event titled Indonesia Townhall on a national television station, Friday (20/11/2020).
So far, the vaccine candidates chosen from China (Sinovac and Sinopharm) by Indonesia can be stored at temperatures between 2 to 8 degrees Celsius. In terms of ability, Indonesia is able to handle it.
"If we have to use Pfizer as an example or Moderna, we have to make another series of procurement for storage with extreme capabilities, minus 70 or minus 20 (degrees Celsius)," Honesti explained.
"In this matter we and the government also stipulate by the Presidential Decree that the type (vaccine) is determined by the Ministry of Health. Of course there are certain criteria that will make Indonesia able to deliver the vaccine faster, starting from its development or procurement, until later distribution and distribution. vaccination program to the community, "he added.
So Indonesian Health Ministry prefer Chinese Vaccine from (Sinovac and Sinopharm) because they don't need Huge Massive Investment to provide Cooling system for such Extreme Cold Temperature ( - 70 degree celcius) for US Vaccine to distribute it across the islands.
Meanwhile Chinese Vaccine from Sinovac & Sinopharm only need 2 to 8 degree celcius for storing and distribution across the islands. It much easier and can use normal refrigerator for distribution.
Anyway Indonesian KALBE FARMA already have a Cooperation Project with SINOVAC and SINOPHARM for National Vaccination Program. Good luck for cooperation of both countries
Advantages of Chinese Covid-19 Vaccines compared to other countries vaccine
Chinese people is famous to make an Efficient but also effective products.
Part of the practicality of Chinese culture
Last edited: